43
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Bone Marrow Angiogenesis and Progression in Multiple Myeloma: Clinical Significance and Therapeutic Approach

, , , &
Pages 937-948 | Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Christine Galustian & Angus Dalgleish. (2009) Lenalidomide: a novel anticancer drug with multiple modalities. Expert Opinion on Pharmacotherapy 10:1, pages 125-133.
Read now
Edgardo S. Santos, Mark Goodman, John J. Byrnes & Hugo F. Fernandez. (2004) Thalidomide Effects in the Post-transplantation Setting in Patients with Multiple Myeloma. Hematology 9:1, pages 35-39.
Read now

Articles from other publishers (10)

Patrizia Leone, Antonio Giovanni Solimando, Marcella Prete, Eleonora Malerba, Nicola Susca, Afshin Derakhshani, Paolo Ditonno, Carolina Terragna, Michele Cavo, Nicola Silvestris & Vito Racanelli. (2023) Unraveling the Role of Peroxisome Proliferator-Activated Receptor β/Δ (PPAR β/Δ) in Angiogenesis Associated with Multiple Myeloma. Cells 12:7, pages 1011.
Crossref
Charlotte Pawlyn & Gareth J. Morgan. (2017) Evolutionary biology of high-risk multiple myeloma. Nature Reviews Cancer 17:9, pages 543-556.
Crossref
Deeksha Vishwamitra, Suraj Konnath George, Ping Shi, Ahmed O. Kaseb & Hesham M. Amin. (2016) Type I insulin-like growth factor receptor signaling in hematological malignancies. Oncotarget 8:1, pages 1814-1844.
Crossref
M Moschetta, Y Mishima, Y Kawano, S Manier, B Paiva, L Palomera, Y Aljawai, A Calcinotto, C Unitt, I Sahin, A Sacco, S Glavey, J Shi, M R Reagan, F Prosper, M Bellone, M Chesi, L P Bergsagel, A Vacca, A M Roccaro & I M Ghobrial. (2016) Targeting vasculogenesis to prevent progression in multiple myeloma. Leukemia 30:5, pages 1103-1115.
Crossref
Gwenny Manel Fuhler, Sander Henricus Diks, Maikel Petrus Peppelenbosch & William Garrow Kerr. (2011) Widespread Deregulation of Phosphorylation-Based Signaling Pathways in Multiple Myeloma Cells: Opportunities for Therapeutic Intervention. Molecular Medicine 17:7-8, pages 790-798.
Crossref
Chun-yan Sun, Yu Hu, Jing Huang, Zhang-bo Chu, Lu Zhang, Xiao-mei She & Lei Chen. (2010) Brain-derived neurotrophic factor induces proliferation, migration, and VEGF secretion in human multiple myeloma cells via activation of MEK-ERK and PI3K/AKT signaling. Tumor Biology 31:2, pages 121-128.
Crossref
F. Owotade, V. Ugboko, S. Ajike, L. Salawu, Y. Amusa & M. Omole. (2005) Head and neck manifestations of myeloma in Nigerians. International Journal of Oral and Maxillofacial Surgery 34:7, pages 761-765.
Crossref
Meletios A. DimopoulosAthanasios AnagnostopoulosDonna Weber. (2003) Treatment of Plasma Cell Dyscrasias With Thalidomide and Its Derivatives. Journal of Clinical Oncology 21:23, pages 4444-4454.
Crossref
Aristotle Bamias & Meletios A Dimopoulos. (2003) Angiogenesis in human cancer: implications in cancer therapy. European Journal of Internal Medicine 14:8, pages 459-469.
Crossref
. (2003) Current Awareness in Hematological Oncology. Hematological Oncology 21:3, pages 141-148.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.